Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A Common Stock, $0.01 par value per share
-
Shares outstanding
-
42M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
20.1M
-
Shares change
-
-1.37M
-
Total reported value, excl. options
-
$14.9M
-
Value change
-
-$1.02M
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$0.74
Significant Holders of RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) as of Q4 2023
26 filings reported holding RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share as of Q4 2023.
RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.1M shares
of 42M outstanding shares and own 47.81% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (8.43M shares), KENNEDY LEWIS MANAGEMENT LP (4.94M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (1.32M shares), ABG-WTT Global Life Science Capital Partners GP Ltd (1.04M shares), BlackRock Inc. (1.02M shares), JPMORGAN CHASE & CO (751K shares), VANGUARD GROUP INC (728K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (700K shares), ADVENT INTERNATIONAL, L.P. (578K shares), and GOLDMAN SACHS GROUP INC (218K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.